PDA

View Full Version : Medical Articles and Abstracts


Pages : 1 [2] 3 4 5

  1. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a
  2. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive
  3. Red blood cell transfusions and nosocomial infections in critically ill patients
  4. Developing a blood conservation program in cardiac surgery
  5. Perioperative intravenous iron, with or without erythropoietin, plus restrictive tran
  6. The clinical benefits of the leukoreduction of blood products
  7. Effects of cell saver autologous blood transfusion on blood loss and homologous blood
  8. Major hepatectomy in children: approaching blood transfusion-free
  9. A randomized, controlled trial of the effects of adding vitamin B12 and folate to ery
  10. Acute normovolemic hemodilution in moderate blood loss surgery: a randomized controll
  11. Persistent effect of red cell transfusion on health-related quality of life after car
  12. Erythrocyte iron incorporation but not absorption is increased by intravenous iron ad
  13. Iron and the anaemia of chronic disease: a review and strategic recommendations
  14. The association between duration of storage of transfused red blood cells and morbidi
  15. Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 st
  16. Risks, benefits, alternatives and indications of allogenic blood transfusions
  17. Fresh blood and aged stored blood are equally efficacious in immediately reversing an
  18. Platelet gel and fibrin sealant reduce allogeneic blood transfusions in total knee ar
  19. Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocy
  20. Transfusion in coronary artery bypass grafting is associated with reduced long-term s
  21. Morbidity and mortality risk associated with red blood cell and blood-component trans
  22. Effect of blood transfusion on outcome after major burn injury: a multicenter study
  23. Does the use of erythropoietin reduce the risk of exposure to allogeneic blood transf
  24. Evidence-based red cell transfusion in the critically ill: quality improvement using
  25. Role of parenteral iron in transfusion requirements after total hip replacement. A pi
  26. Diagnosis and management of iron-related anemias in critical illness
  27. The impact of an hematocrit of 20% during normothermic cardiopulmonary bypass for ele
  28. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red bloo
  29. Red blood cell transfusion practices amongst Canadian anesthesiologists: a survey
  30. Fluid challenge revisited
  31. Intraoperative Blood Salvage in Penetrating Abdominal Trauma: a Randomised, Controlle
  32. A head-to-head comparison of the in vitro coagulation effects of saline-based and bal
  33. The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled t
  34. Preoperative epoetin alfa vs autologous blood donation in primary total knee arthropl
  35. Influence of hemoglobin levels on inpatient rehabilitation outcomes after total knee
  36. Anemia, transfusion and phlebotomy practices in critically ill patients with prolonge
  37. Role of parenteral iron in transfusion requirements after total hip replacement. A pi
  38. A head-to-head comparison of the in vitro coagulation effects of saline-based and bal
  39. Recombinant activated factor VII in the treatment of near-fatal bleeding during pedia
  40. Prediction of the effect of acute normovolemic hemodilution on the hematological cons
  41. Reduction of postoperative spinal infections based on an etiologic protocol.
  42. Predicting late anemia in critical illness.
  43. Phase III study of two different dosing schedules of erythropoietin in anemic patient
  44. A propensity score case-control comparison of aprotinin and tranexamic acid in high-
  45. Effectiveness of darbepoetin-alfa in combination with intravenous iron sucrose in pat
  46. Local infusion of norepinephrine reduces blood losses and need of transfusion in tota
  47. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surger
  48. Blood transfusion in critically injured patients: a prospective study.
  49. Blood viscosity maintains microvascular conditions during normovolemic anemia indepen
  50. Perioperative red cell, plasma, and blood volume change in patients undergoing cardia
  51. A prospective study investigating the cost effectiveness of intraoperative blood salv
  52. Cost, quality, and risk: measuring and stopping the hidden costs of coronary artery b
  53. Every 3 weeks dosing with darbepoetin alfa: A new paradigm in anaemia management.
  54. Comparison of lactated Ringer's, gelatine and blood resuscitation on intestinal oxyge
  55. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery
  56. Blood transfusion is associated with infection and increased resource utilization in
  57. Does salvage and tranexamic acid reduce the need for blood transfusion in revision hi
  58. Darbepoetin-alpha for the anaemia of myelofibrosis with myeloid metaplasia
  59. Anemia, allogenic blood transfusion, and immunomodulation in the critically ill
  60. Perioperative use of recombinant activated factor VII in a Jehovah's Witness patient
  61. Blood loss after total hip replacement: a prospective randomized study between wound
  62. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a
  63. Perioperative intravenous iron, with or without erythropoietin
  64. Development and validation of Transfusion Risk Understanding Scoring Tool (TRUST) to
  65. Acute normovolemic hemodilution in moderate blood loss surgery: a randomized controll
  66. Blood transfusion is associated with infection and increased resource utilization
  67. The association between duration of storage of transfused red blood cells and morbid
  68. Effects of cell saver autologous blood transfusion on blood loss and homologous blood
  69. New generation cytokines to prevent anemia and febrile neutropenia
  70. Pediatric critical care community survey of knowledge and attitudes toward therapeuti
  71. Therapeutic hypothermia utilization among physicians after resuscitation from cardiac
  72. Absorbable laparoscopic cigarette sponge.
  73. Resolving the paradigm crisis in intravenous iron and erythropoietin management.
  74. Blood management in total joint arthroplasty
  75. Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systemati
  76. Developing a blood conservation program in cardiac surgery.
  77. A provincial program of blood conservation: The Ontario Transfusion Coordinators (ONT
  78. The effect of older blood on mortality, need for ICU care, and the length of ICU stay
  79. Massive transfusion as a risk factor for acute lung injury: association or causation?
  80. Are i-STAT results adversely affected by an artificial blood substitute in vivo?
  81. Early administration of a second-generation perfluorochemical decreases ischemic brai
  82. Socioeconomic costs of open surgery and gamma knife radiosurgery for benign cranial b
  83. Brain Surgery Without The Surgery?
  84. Pneumonia as a complication of blood product transfusion
  85. Substitute blood development suffers blow
  86. Special scalpel reduces blood loss, facial nerve trauma in salivary surgery
  87. Older Blood Associated With Worse Outcomes After Repeat Heart Surgery
  88. Minimally Invasive Procedure Restores Blood Flow To Kidneys, Research Suggests
  89. Pancreaticoduodenectomy after neoadjuvant therapy in a Jehovah's witness with locally
  90. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery
  91. Erythropoietin: can we afford to use it? Can we afford not to?
  92. Safety aspects of aprotinin therapy in cardiac surgery patients.
  93. Persistent Effect of Red Cell Transfusion on Health-Related Quality of Life After Car
  94. TRALI in 2 Cases of Leukemia.
  95. TRALI-Soluble CD40 ligand accumulates in stored blood components, primes neutrophils
  96. Blood management in intensive care medicine: CRIT and ABC – what can we learn?
  97. The effects of colloid solutions on hemostasis
  98. Erythropoietin is an effective clinical modality for reducing RBC transfusion
  99. Transfusion in CABG is associated with reduced long-term survival
  100. Thoracoscopic Spinal Fusion Compared with Posterior Spinal Fusion
  101. Morbidity and mortality risk associated with red blood cell and blood-component trans
  102. Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of rand
  103. Perioperative blood transfusions increase infectious complications after ileoanal po
  104. Tranexamic acid reduces postoperative bleeding in off-pump coronary artery bypass gra
  105. Effect of blood transfusion on outcome after major burn injury: A multicenter study
  106. Iron-Clad Solutions to Anemia
  107. Comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery
  108. Effectiveness of Darbepoetin-Alfa in Combination with Intravenous Iron Sucrose
  109. Blood Transfusions Could Transmit Variant Creutzfeldt-Jakob
  110. A prospective randomized trial toward a "blood transfusion"-free hepatectomy.
  111. Blood utilisation in elective surgery cases: requirements, ordering and transfusion
  112. Timing of the administration of tranexamic acid for maximum reduction in blood loss
  113. An audit of blood cross-match ordering practices at the Aga Khan University Hospital
  114. UK - The impact of a 10-year audit cycle on blood usage in district general hospital
  115. Use of red blood cell transfusions in surgery
  116. The quest for quality blood banking program in the new millennium the American way
  117. A questionnaire study about perioperative blood transfusion
  118. New blood transfusion system of the Saku Central Hospital--conditions and problems
  119. [Allogeneic blood transfusion policy in orthopedic surgery]
  120. A study of blood cross-matching requirements for surgery in gynecological oncology: i
  121. Transfusion-free cardiopulmonary bypass in Jehovah's Witness patients weighing <5kg
  122. Blood transfusions linked - increased mortality - patients suffering cardiac episodes
  123. Rethinking blood shield statutes in view of the hepatitis C pandemic
  124. Babesiosis and blood transfusion: flying under the radar
  125. Aprotinin in cardiac surgery
  126. The potential for reintroduction of tumor cells during intraoperative blood salvage:
  127. Recent developments - Blood transfusion medicine
  128. New Research Emerges on Dangers of Blood Loss
  129. Commonly Used Drug in Heart Surgery May Increase Risk of Death
  130. NEJM - The Risk Associated with Aprotinin in Cardiac Surgery
  131. Heart attack patients do better in America's “best” hospitals
  132. Cancer Patients Do Better With Surgeons, Hospitals That Treat Higher Volume
  133. Heart Attack Patients Do Best at Hospitals That Specialize
  134. NovoSeven - Off-Label Use of Hemophilia Drug May Be Risky
  135. Results- Perfusion.com Cardiac Hematocrit Trend Survey:Observations/Recommendations
  136. Immunosuppression, Skin Cancer, and Ultraviolet A Radiation
  137. Cardiac Surg Abstracts
  138. Blood ordering protocol based on proposed surgical implant in fractured neck of femur
  139. Can EPO reduce blood transfusion requirements induction therp high-risk neuroblastoma
  140. Effect of substituting allogenic blood transfusion with autologous blood transfusion
  141. Allogeneic blood transfusion and wound healing disturbance after orthopaedic surgery
  142. The transfusion services committee--responsibilities and response to adverse transfus
  143. Getting the right blood to the right patient
  144. Alternative to platelet transfusion in aplastic anemia
  145. Long-term transfusion of polymerized bovine hemoglobin in a Jehovah's Witness followi
  146. Off-Pump Repair of a Giant Pseudoaneurysm of a Distal Saphenous Vein Bypass Graft
  147. Overview of Clinical Efficacy and Safety of Pharmacologic Strategies for Blood Conser
  148. Blood Conservation Strategy Can Eliminate Phlebotomy Waste
  149. Blood conservation in pediatric anesthesia
  150. Blood conservation in the critically ill patient
  151. Artificial oxygen carriers as an alternative to red blood cell transfusion
  152. Transfusion management
  153. Evaluation and management of bleeding during cardiac surgery
  154. Bloodless surgery of acute type A aortic dissection in a Jehovah's Witness patient
  155. Theme issue on Ontario initiatives in blood conservation and blood management
  156. A provincial program of blood conservation The Ontario Transfusion Coordinators-ONTC
  157. Overview of clinical efficacy and safety of pharmacologic strategies for blood conser
  158. Are we doing everything we can to conserve blood during bypass? A national survey
  159. Hemobag - Article shows Blood Reduction in Cardiac Surgery
  160. .... lifeline for saving the critically injured on the battllefield
  161. Common Anemias
  162. Blood management strategies for critical care patients
  163. A Practical Approach to Achieving Bloodless Surgery.
  164. Clinical results of Perftoran application: present and future
  165. Surgeries on gastrointestinal tract without components of donor's blood
  166. Preoperative embolization of intracranial meningiomas with Embosphere microspheres
  167. Bloodless treatment of infants with haemolytic disease
  168. Fresh frozen plasma transfusion in critically ill medical patients with coagulopathy.
  169. Determinants of red blood cell transfusions in a pediatric critical care unit: A pros
  170. Transfusion-transmitted infection in hemophilia in developing countries.
  171. Current trends in blood conservation in total knee arthroplasty
  172. Preoperative iron supp and intraoperative transfusion colorectal cancer surgery
  173. Blood conservation: the CEO perspective
  174. Cardiopulmonary bypass: it's not the size, it's how you use it! Blood Conservation
  175. Transfusion-free pediatric burn surgery: techniques and strategies.
  176. Impact of extracorporeal circuit prime volume reduction on whole blood sequestration
  177. Orthopaedic-induced anemia: the fallacy of autologous donation programs
  178. Intraoperative blood salvage: fluid replacement calculations
  179. Red Cell Transfusion "Trigger": A Review
  180. Indications for Blood Transfusion in Critical Care Patients Reviewed CME
  181. No-Transfusion Liver Graft in Surgical Tour de Force
  182. Cardioprotective effects of acute normovolemic hemodilution in patients undergoing co
  183. Effects of early intervention with epoetin alfa on transfusion requirement, hemoglobi
  184. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injure
  185. Evaluation and management of bleeding during cardiac surgery
  186. Aprotinin decreases postoperative bleeding and number of transfusions in patients on
  187. Recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery
  188. Preoperative erythropoietin therapy
  189. Know more about Chagas Disease
  190. ESC: Lovenox Reduces Bleeding in Elective Angioplasty
  191. Blood Conservation
  192. Recombinant Human Erythropoietin Use in a Critically Ill Jehovah’s Witness After Card
  193. Safety, efficacy, and cost of intraoperative cell salvage and autotransfusion CABG
  194. Restoring Flow to All Blocked Areas of the Heart Improves 5-Year Survival Rate
  195. Hep C-Related Deaths Expected to Triple over Next 10 Years; New Treatments Years Off
  196. New UK Guidance to be issued on Hepatitis C as 'silent epidemic'
  197. Safety Of Polymerizedbovine Hemoglobin As Compared To Rbc
  198. Heart attack patients who receive blood transfusions have higher death rate
  199. Prophylactic recombinant factor VIIa in haemophilia patients with inhibitors.
  200. Therapeutic approaches in trauma-induced coagulopathy.
  201. Which may be effective to reduce blood loss after cardiac operations in cyanotic chil
  202. Coagulation disorders and blood product use in patients undergoing thoracoabdominal a
  203. Aprotinin inhibits protease-dependent platelet aggregation and thrombosis.
  204. Evidence-based review of the role of aprotinin in blood conservation during orthopaed
  205. A review of aprotinin in orthotopic liver transplantation: can its harmful effects of
  206. Therapeutic approaches in trauma-induced coagulopathy.
  207. Perioperative stimulation of erythropoiesis with intravenous iron and erythropoietin
  208. Number needed to treat and cost of recombinant human EPO to avoid one transfusion
  209. Cost-effectiveness of recombinant human erythropoietin for reducing RBC Transfusion
  210. Use of acute normovolemic hemodilution in patients undergoing radical prostatectomy
  211. The safety and efficacy of "bloodless" cardiac surgery
  212. To do or not to do living donor hepatectomy in Jehovah's Witnesses
  213. Clinical Outcomes in Cardiac Surgery: Conventional Surgery versus Bloodless Surgery
  214. Study Gives Survival Edge to CABG Over Stenting
  215. Parens Patriae explained - (We need a legal forum!!)
  216. Current Issues in Transfusion Medicine, An Issue of Anesthesiology Clinics
  217. 1976 Article - Old and new dangers of blood transfusion
  218. 1968 Article - Assessment of risk and danger of blood transfusion
  219. 1963 Article - THE INCREASED IMMUNOLOGICAL DANGER OF MULTIPLE TRANSFUSIONS
  220. 1950 Article - Danger of leukemia transmission by blood transfusion
  221. 1951 Article - The extent of danger in intrasternal blood transfusion
  222. 1952 Article - DANGER of blood transfusion
  223. 1953 Article - WORLD Health Organization; danger of spreading jaundice through BT
  224. 1953 Article - Danger of universal donors
  225. 1955 Article - The problem of reducing the danger of serum
  226. 1956 Article - Pyrogenic substances as a source of danger in blood transfusion
  227. 1957 Article - The danger of transmission of Chagas' disease by blood transfusion
  228. 1953 Article - BLOOD transfusion: danger of serum hepatitis
  229. [Radiofrequency ablation of liver tumours]
  230. Usefulness of vacuum-assisted cardiopulmonary bypass circuit for pediatric open-heart
  231. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: l
  232. Randomized trial of normal saline solution injection versus bipolar electrocoagulatio
  233. Partial nephrectomy using a vascular sealing system.
  234. Cardiopulmonary bypass copolymer surface modification reduces neither blood loss nor
  235. Argon beam coagulation for post-tonsillectomy hemostasis.
  236. Effect of hypoventilation on bleeding during hepatic resection: a randomized controll
  237. Prediction of therapeutic failure after adrenaline injection plus heater probe treatm
  238. The effects of quantum energy surgical device and of bipolar coagulation: a comparati
  239. Minimising intra-operative blood loss.
  240. Minimal blood loss in patients undergoing radical retropubic prostatectomy
  241. Prophylactic positive end-expiratory pressure and reduction of postoperative blood lo
  242. Progress in ascending and aortic arch surgery: minimally invasive surgery, blood cons
  243. The use of tourniquets in the excision of unexsanguinated extremity burn wounds.
  244. Argon beam coagulation during caesarean section.
  245. Reoperation in a Jehovah's Witness 22 years after aortic allograft reconstruction of
  246. How we do a bloodless partial splenectomy
  247. Laparoscopic nephron-sparing surgery in a Jehovah's Witness patient
  248. Blood Safety/Danger Articles
  249. It is now (2004) clear that there is a risk from the transmission of vCJD via blood
  250. The impact of weekly dosing of epoetin alfa on the haematological parameters and on t